Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Interferon alpha/beta receptor 1 (IFNAR1) is a type I membrane protein and one of two essential subunits of the receptor complex for type I interferons, including interferons alpha and beta. The IFNAR complex is virtually ubiquitous, present on most cell types, and mediates cellular responses to endogenous type I interferon cytokines. Upon binding to a type I interferon, the two subunits come together to form an active signaling complex, activating the JAK/STAT pathway and leading to antiviral responses, inhibition of cell proliferation, and modulation of immune activity.
Binding of type I interferons (IFN-alpha or IFN-beta) to IFNAR1 and IFNAR2 leads to receptor dimerization and activation of the JAK/STAT pathway.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Interferon alpha/beta receptor 1.